Charme Capital Partners
Charme Capital Partners is a private equity firm established in 2003, headquartered in Milan, Italy, with additional offices in London and Madrid. The firm specializes in investing in mid-market companies across Europe, particularly those with an enterprise value between €100 million and €500 million. Charme Capital Partners focuses on sectors such as commercial services, consumer durables, healthcare devices, software, manufacturing, and industrial services. The firm is dedicated to collaborating with management teams and shareholders to facilitate transformational changes, foster growth, and support international expansion of its portfolio companies. Engaging continuously with its investor base is essential for Charme Capital Partners in identifying new investment opportunities and validating its investment strategies.
Veritas Intercontinental
Series B in 2020
Veritas Intercontinental, S.L., based in Madrid, Spain, specializes in whole genome sequencing and interpretation services. Founded in 2004, the company offers a range of genetic tests designed to provide insights into hereditary diseases, medication responses, and ancestry. Its key offerings include myGenome, which assesses risks for hereditary diseases and medication responses; myNewbornDNA, aimed at identifying genetic diseases in newborns; myCancerRiskDNA, which evaluates cancer risk; and myDiagnostic, for patients with potential hereditary genetic conditions. Veritas aims to empower individuals to enhance their health and longevity through actionable genetic information. The company has been recognized for its innovative contributions to genomics, having received accolades from MIT Technology Review, Fast Company, and CNBC.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.